Obtaining an accepted Investigational New Drug application to operate an umbilical cord blood bank

Transfusion

Volumn 39, Issue 4, 1999, Pages 357-363

  Reems, Jo Ann ^a   Fujita, Deanna ^d   Tyler, Tom ^b   Moldwin, Richard ^d   Smith, Stephen D ^c  

^a Blood Systems Laboratories   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD STORAGE; FOOD AND DRUG ADMINISTRATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; UMBILICAL CORD BLOOD;

EID: 0032926938     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39499235666.x     Document Type: Article

References (28)

1. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989;86:3828-32.
2. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-8.
3. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
4. Wagner JE, Kernan NA, Steinbuch M, et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346:214-9.
5. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
6. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
7. Greenwald HR, Harden VA, eds. The regulation of biologic products 1902-1972. Intramural Contributions 1887-1987. Washington: Department of Health and Human Services, National Institute of Allergy and Infectious Disease, 1987.
8. Request for proposed Standards for Unrelated Allogeneic Peripheral and Placental/Umbilical Cord Blood Hematopoietic Stem/Progenitor Cell Products; request for comments (Docket No. 97N-0497). Fed Regist 1998;63(12):2985-8.
9. The Food and Drug Administration's development, issuance, and use of guidance documents (Docket No. 95P-0110). Fed Regist 1997;62(39):8961-72.
10. 21 CFR, Part 312, Subparts A-G. Washington: Government Printing Office, 1997 (revised annually).
11. 21 CFR, Part 50, Subparts A-C. Washington: Government Printing Office, 1997 (revised annually).
12. 21 CFR, Part 56, Subparts A-D. Washington: Government Printing Office, 1997 (revised annually).
13. Scribner C. Pitfalls, snares, snags, and downright awful IND submissions for biologics. Regul Affairs 1991;3:241-7.
14. Menitove J, ed. Standards for hematopoietic progenitor cells. Bethesda: American Association of Blood Banks, 1996.
15. Warkentin P. Standards for hematopoietic progenitor cell collection, processing and transplantation. Omaha, NE: North America Foundation for the Accreditation of Hematopoietic Cell Therapy, 1996.
16. Weitekamp L, ed. Standards for the National Marrow Donor Program. 15th ed. Minneapolis: National Marrow Donor Program, 1997.
17. 21 CFR, Part 210-211, Subparts A-K. Washington: Government Printing Office, 1997 (revised annually).
18. Proposed approach to regulation of cellular and tissue-based products (Docket No. 97N-0068). Fed Regist 1997;62:9721-2.
19. FDA holds meeting on regulation of cellular and tissue-based products. International Society for Hematotherapy and Graft Engineering. ISHAGE Telegraft 1997;4:4-6.
20. Gluckman E. Cord blood banking and transplantation in Europe. In: Broxmeyer HE, ed. Cellular characteristics of cord blood and cord blood transplantation, Bethesda: AABB Press, 1998:147-64.
21. Menitove JE, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda: American Association of Blood Banks, 1997.
22. Rubinstein P, Dorbrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-22.
23. Series 095 Reporting Forms, Follow-up Core and Donor Information Forms. International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry. Milwaukee: Medical College of Wisconsin, 1995:1-26 and 1-10.
24. To BL, Shepherd M, Lam-Po-Tang R, et al. Guidelines for the collection, processing, storage, and of administration of hemopoietic stem and progenitor cells for transplantation. Report of the Working Party on Hemopoietic Stem Cell Processing, Hematology Discipline Advisory Committee, the Royal College of Pathologists of Australia. Pathology 1998;30:276-B5.
25. Cordnews 1997;1(4).(http://polic.cilea.it/ctit/milancord/ cordnews/newsindex.htm).
26. ™9000. Methuen, MA: GOAL/QPC, 1996:1-3.
27. Broxmeyer HE. Introduction: the past, present, and future of cord blood transplantation. In: Broxmeyer HE, ed. Cellular characteristics of cord blood and cord blood transplantation. Bethesda: AABB Press, 1998:1-9.
28. Cordnews 1998;2(2). (http://polic.cilea.it/ctit/milancord/ cordnews/newsindex.htm).